Nuritas™ Raises $45 Million To Scale Its Peptide Discovery Platform And Expand Globally DUBLIN -Friday 12 November 2021

(BUSINESS WIRE)-- Nuritas, a biotechnology company revolutionizing the discovery and development of plant-based bioactive peptides, has closed a $45 million USD Series B funding round. The investment, led by Chicago-based Cleveland Avenue, LLC, includes Grosvenor’s Wheatsheaf Group, the...